Abnormal response to methylphenidate across multiple fMRI procedures in cocaine use disorder: feasibility study.
Abnormal response to methylphenidate across multiple fMRI procedures in cocaine use disorder: feasibility study.
复制标题
可卡因使用障碍中多个功能磁共振成像程序对哌醋甲酯的异常反应:可行性研究。
DOI:
10.1007/s00213-016-4307-9
复制
发表时间:
2016
影响因子:
3.4
通讯作者:
Goldstein,RitaZ
中科院分区:
文献类型:
--
作者:
Moeller,ScottJ;Konova,AnnaB;Tomasi,Dardo;Parvaz,MuhammadA;Goldstein,RitaZ
RationaleThe indirect dopamine agonist methylphenidate remediates cognitive deficits in psychopathology, but the individual characteristics that determine its effects on the brain are not known.ObjectivesWe aimed to determine whether targeted dopaminergically modulated traits and individual differences could predict neural response to methylphenidate across multiple functional magnetic resonance imaging (fMRI) procedures.MethodsWe combined neural measures from three separate procedures (two inhibitory control tasks differing in their degree of emotional salience and resting-state functional connectivity) during methylphenidate (20 mg oral, versus randomized and counterbalanced placebo) and correlated these aggregated responses with cocaine use disorder diagnosis (22 cocaine abusers, 21 controls), symptoms of attention deficit hyperactivity disorder, and working memory capacity.ResultsCocaine abusers, relative to controls, had a lower response in the dorsolateral prefrontal cortex to methylphenidate across all three procedures, driven by responses to the two inhibitory control tasks; reduced methylphenidate fMRI response in this region further correlated with more frequent cocaine use.ConclusionsCocaine abuse (and its frequency), associated with lower tonic dopamine levels, correlated with a reduction in activation to methylphenidate (versus placebo). These initial results provide feasibility to the idea that multimodal fMRI tasks can be meaningfully aggregated, and that these aggregated procedures show a common disruption in addiction in a highly anticipated region relevant to cognitive control. Results also suggest that drug use frequency may represent an important modulatory variable in interpreting the efficacy of pharmacologically enhanced cognitive interventions in addiction.